Unlock instant, AI-driven research and patent intelligence for your innovation.

Glu-Asp-Gly modified methotrexate, and synthesis, anti-metastasis activity and application of Glu-Asp-Gly modified methotrexate

A glu-asp-gly, methotrexate technology, applied in the field of biomedicine, can solve the problems of limiting the application and curative effect of methotrexate

Active Publication Date: 2020-12-18
CAPITAL UNIVERSITY OF MEDICAL SCIENCES
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, bone marrow toxicity, liver toxicity, nephrotoxicity, oral mucosal side effects and drug resistance severely limit the application and efficacy of methotrexate.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Glu-Asp-Gly modified methotrexate, and synthesis, anti-metastasis activity and application of Glu-Asp-Gly modified methotrexate
  • Glu-Asp-Gly modified methotrexate, and synthesis, anti-metastasis activity and application of Glu-Asp-Gly modified methotrexate
  • Glu-Asp-Gly modified methotrexate, and synthesis, anti-metastasis activity and application of Glu-Asp-Gly modified methotrexate

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Example 1 Preparation of Boc-Asp(OBzl)-Gly-OBzl(1)

[0017] 1.42 g (4.40 mmol) of Boc-Asp (OBzl) was dissolved in 60 mL of anhydrous tetrahydrofuran to obtain No. 1 solution. 0 ℃ and stirring, 1.36g (6.60mmol) dicyclohexyl carbodiimide and 0.59g (4.40mmol) N-hydroxybenzotriazole anhydrous tetrahydrofuran solution was added to the No. 1 solution and stirred for 30 minutes. Subsequently, 1.10 g (3.26 mmol) Tos Gly-OBzl was added, the pH of the reaction solution was adjusted to 8-9 with N-methylmorpholine, the ice bath was removed, and after 18 hours of thorough stirring at room temperature, TLC (dichloromethane / Methanol = 30 / 1) showed the reaction was complete. The colorless solid in the reaction solution was filtered off, the filtrate was concentrated, the residue was dissolved in 100 mL of ethyl acetate, and the solution was washed successively with saturated aqueous sodium bicarbonate (30 mL×3) and saturated aqueous sodium chloride (30 mL×3). , washed with 5% potass...

Embodiment 2

[0018] Example 2 Preparation of Asp(OBzl)-Gly-OBzl(2)

[0019] Dissolve 1.34g (2.85mmol) Boc-Asp(OBzl)-Gly-OBzl(1) in anhydrous ethyl acetate, add 20mL hydrogen chloride in ethyl acetate solution (4M) under stirring at 0°C, and stir for 7 hours TLC (dichloromethane / methanol=30 / 1) showed that the reaction was complete. Under the condition of warm water bath, the reaction solution was repeatedly concentrated under reduced pressure, and then the concentrate was dissolved with anhydrous ethyl acetate, and the reaction solution was repeatedly concentrated under reduced pressure (3 times). The reactant was washed repeatedly with anhydrous ether to obtain 1.05 g (100%) of the target compound as a yellow viscous oil. ESI-MS(m / e):371[M+1] + .

Embodiment 3

[0020] Example 3 Preparation of Boc-Glu(OBzl)-Asp(OBzl)-Gly-OBzl(3)

[0021] Using the method of Example 1, 1.31 g (77%) of the target compound was obtained as a colorless powder from 0.83 g (2.47 mmol) of Boc-Glu (OBzl) and 1.05 g (2.84 mmol) of compound (2). ESI-MS(m / e):690[M+H] + , 1H NMR (300MHz, DMSO-d 6 ):δ / ppm=8.32(t, J=5.7Hz, 1H), 8.24(d, J=8.1Hz, 1H), 7.39-7.30(m, 15H), 7.03(d, J=7.8Hz, 1H) ,5.10-5.06(m,6H),4.71(m,1H),3.90(m,3H),2.81(dd,J=8.4Hz,5.1Hz,2H),2.52(m,2H),1.83(m, 2H), 1.36(s, 9H).

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses Glu-Asp-Gly modified methotrexate of the following general formula (in the formula, when R1 is Glu-Asp-Gly, R2 is OH, when R1 is OH, R2 is Glu-Asp-Gly, and R1 and R2 are Glu-Asp-Gly at the same time), a preparation method of the compounds, and an inhibition effect of the compounds on tumor metastasis. Therefore, the invention discloses application of the compounds in preparing anti-tumor metastasis drugs.

Description

technical field [0001] The present invention relates to Glu-Asp-Gly modified methotrexate, their preparation method and their anti-tumor metastasis effect. Therefore, the present invention relates to their application in the preparation of anti-tumor metastasis drugs. The invention belongs to the field of biomedicine. Background technique [0002] Cancer refers to the uncontrolled and abnormal proliferation of cells, which has the opportunity to spread to other parts of the body through the blood system or lymphatic system. It is a major medical problem worldwide. According to the data on the incidence and death of malignant tumors in various regions of my country in 2015 released by the National Cancer Center in early 2019, leukemia ranks among the top ten malignant tumors with the highest mortality rate. As one of the earliest drugs used to treat acute leukemia, methotrexate has a clinical application history of more than 70 years. However, bone marrow toxicity, liver t...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K5/113C07K5/037C07K7/02C07K1/06C07K1/02A61K38/07A61K38/08A61P35/04
CPCC07K5/1021C07K5/0215C07K7/02A61P35/04A61K38/00Y02P20/55
Inventor 赵明彭师奇梁梦
Owner CAPITAL UNIVERSITY OF MEDICAL SCIENCES